CUSIP N71542109SHS EUROQ4 2025
43 filings · latest Feb 6, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Adage Capital Partners Gp, L.L.C. | 6.25M | $12.63M |
| 2 | Privium Fund Management B.V. | 5.36M | $10.82M |
| 3 | Aberdeen Group PLC | 2.95M | $5.96M |
| 4 | Affinity Asset Advisors, LLC | 2.45M | $4.96M |
| 5 | Sio Capital Management, LLC | 2.16M | $4.37M |
| 6 | Dafna Capital Management LLC | 1.57M | $3.17M |
| 7 | Kynam Capital Management, LP | 1.57M | $3.16M |
| 8 | Ikarian Capital, LLC | 1.49M | $3.01M |
| 9 |
| 4 | Sep 4, 2025 | Van Herk Investments B.V. | 13D/A | 12.6% | — | SEC |
| 5 | Aug 20, 2025 | Van Herk Investments B.V. | 13D/A | 11.6% | — | SEC |
| 6 | Aug 12, 2025 | Adage Capital Management, L.P. | 13G/A | 6.3% | 6.60M | SEC |
| 7 | May 28, 2025 | Van Herk Investments B.V. | 13D | 10.9% | — | SEC |
| 8 | May 12, 2025 | Adage Capital Management, L.P. | 13G/A | 7.7% | 8.10M | SEC |
| 9 | Feb 14, 2025 | Van Herk Investments B.V. | 13G/A | 10.9% | 11.46M | SEC |
| 10 | Feb 12, 2025 | Adage Capital Management, L.P. | 13G | 9.3% | 9.60M | SEC |
See the full Schedule 13D/13G history for Proqr Thrapeutics N V.
Unlock full history| Morgan Stanley |
| 1.37M |
| $2.76M |
| 10 | Platinum Investment Management Ltd | 1.24M | $2.50M |